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Abstract
Ultrasound is utilized for many purposes in medicine, beauty care, industry and consumer 
products. In the past years, the use of ultrasound has increased particularly in the field of 
beauty care, where it has applications such as skin cleansing, fat removal and facilitating 
conditioner absorption. At worst, the use of ultrasound may have serious health effects, 
and therefore ensuring safety is essential. Factors that significantly affect safety include 
equipment technology, the skills of the user, the instructions provided and the state of 
health of the customer.
The medical use of ultrasound is subject to the Radiation Act (592/1991). The Radiation 
Act specifies no limits to ultrasound exposure. The safety of medical equipment is also 
regulated by the Act on Healthcare Equipment and Supplies (629/2010). Nowadays, lim-
iting the non-medical ultrasound exposure of members of the public is necessary, as the 
use and applications of ultrasound in consumer products and beauty care services have 
increased significantly. Limitations to ultrasound should be taken into account in the major 
overhaul of the Radiation Act.
The health effects of ultrasound have been discussed in overviews by international spe-
cialist organizations. The International Commission on Non-Ionizing Radiation Protec-
tion (ICNIRP) and the World Health Organization have assessed the health effects of 
airborne ultrasound. Nowadays, particularly in beauty care, ultrasound exposure occurs 
in direct skin contact, and the effects of ultrasound may reach the entire body. Many 
international organizations, including the World Federation for Ultrasound in Medicine 
and Biology (WFUMB), the Advisory Group on Non-Ionizing Radiation (AGNIR) and the 
Strahlenschutzkommission (SSK) have made recommendations for the safe use of ultra-
sound in exposure through skin contact.
This report presents the purposes of use of ultrasound, its health effects and the interna-
tional recommendations for limiting exposure to it. The report pays special attention to 
the use of ultrasound in beauty care and offers a suggestion for limiting non-medical ex-
posure to ultrasound in the upcoming Radiation Act. In addition, the report specifies the 
contraindications that should be taken into account in ultrasound treatments in beauty 
care.
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1 Introduction
The aim of this project was to establish ways to 
ensure the safety of ultrasound in beauty care and 
other non-medical applications, as well as to seek 
ways to organize regulation, regulatory control 
and guidance appropriately to prevent health 
risks from the use of ultrasound without imposing 
unnecessary restrictions to practices. The results 
of the project are intended to be utilized in the 
major overhaul of the Radiation Act. The report 
briefly describes the use of ultrasound and the 
technology of equipment that produces ultrasound, 
as well as possible health hazards, legislation and 
standardization. In addition, a short chapter has 
been dedicated to discussing infrasound and its 
safety.
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2 Basic information on ultrasound
2.1 What is ultrasound?
Ultrasound refers to mechanical waves with 
frequencies higher than the upper audible limit 
of human hearing (> 20 kHz). Ultrasound always 
requires a medium to propagate, using pressure 
variations  for propagation. Ultrasound propagates 
well in liquid media, but will not propagate 
through a vacuum. The shape of the ultrasound 
beam depends on the geometry and frequency of 
the source. In practical applications, ultrasound 
normally contains several frequencies. The beam 
can be modified, which is utilized especially in 
diagnostic applications.
In addition to the frequency, describing an 
ultrasound field requires knowledge of the sound 
pressure, referring to the difference between 
the ambient atmospheric pressure and the local 
pressure caused as a sound wave passes the 
observation point. The attenuation of ultrasound 
depends on the frequency and the properties of the 
medium, and may therefore not occur predictably 
and evenly. At the interface of media, a part of the 
ultrasound is reflected, while some is refracted 
as it propagates to the other side of the interface. 
Ultrasound’s behavior on the interface depends 
on the properties of the media. On the interface 
of the bone, reflection is strong, and at an air 
interface, ultrasound is almost entirely reflected. 
For ultrasound imaging and procedures, coupling 
gel is placed between skin and the transmitter in 
order to improve the propagation of ultrasound 
inside the body.
In practical applications, the ultrasound wave 
is typically focused by using a suitably shaped 
source or a lens or some other means. Focusing 
the wave improves the resolution in diagnostics. 
Due to the greater intensity achieved through 
focusing, ultrasound may also be used to break 
selected targets, such as kidney stones. Detailed 
information on the basics of ultrasound is available 
in reports by HPA and SSK (HPA 2010, SSK 2012) 
and Leighton’s publication (2007).
The article by INIRC (1985) covers the 
definitions, quantities, units and terminology 
concerning protection from non-ionizing radiation. 
Ultrasound has been included in non-ionizing 
radiation. The quantities used to establish exposure 
limits for ultrasound are acoustic intensity (W/m²) 
and, for airborne ultrasound, sound pressure (dB).
2.2 Purposes of use of ultrasound
Ultrasound is utilized for various purposes in the 
fields of medicine, beauty care services, industry 
and consumer products. In the last few years, new 
types of applications have been introduced at an 
increasing pace. The difference between medical 
and beauty care-related procedures is somewhat 
ambiguous, as the same procedures are performed 
for both medical and cosmetic purposes, sometimes 
also with the same equipment. Examples of 
purposes of use of the equipment are listed below, 
adapted from the Ahmadi publication (2012).
Medical applications of imaging and treatments 
include:
•	 ultrasound scans (e.g., fetuses and internal 
organs)
•	 ultrasonic drug delivery (sonophoresis, 
phonophoresis)
•	 dental cleaning, removal of dental calculus and 
root canal therapy
•	 different types of removals and lithotripsy 
(including kidney stones and gallstones, blood 
clots)
•	 surgery
•	 ocular surgery
•	 fat removal
•	 the absorption of medicinal substances.
Beauty care applications include:
•	 skin scrubbing
•	 fat removal
•	 hair removal
•	 skin cleansing
•	 the absorption of conditioners.
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Industrial applications include:
•	 ultrasound cleaning
•	 soldering
•	 welding plastic and metal
•	 processing and polishing parts
•	 material quality control.
Home use applications include:
•	 ultrasound washers
•	 door openers
•	 remote controls
•	 burglar alarm systems
•	 pest repellants
•	 guidance devices for the blind
•	 fetal heartbeat monitoring device.
Other applications include:
•	 3D and 4D imaging of the fetus for non-medical 
purposes
•	 localization and navigation in water and air 
(SONAR and SODAR).
2.3 Effects of ultrasound 
on the human body
Airborne ultrasound primarily affects the external 
organs of the body, such as ears and eyes. In 
medical and beauty care-related procedures, 
equipment utilizing ultrasound is used with direct 
skin contact. The treatment head of the device is 
typically moved around during the procedure. The 
equipment’s effects on the body are either based 
on the tissue warming up (thermal effect) or the 
cavitation phenomenon. 
Thermal effect
When used at higher frequencies, the effect 
ultrasound has on the tissue is based on heating. 
The thermal effect normally becomes dominant 
when the frequency is increased from kilohertz 
(kHz) to megahertz (MHz) levels. Equipment based 
on the utilization of the thermal effect can be used 
with focused high power. These devices are often 
called HIFU (high intensity focused ultrasound) 
or HITU (high intensity therapeutic ultrasound) 
devices, and they have been used in surgical 
procedures for years (Lindberg 2013).
Cavitation
Ultrasound waves are propagated through tissue 
via pressure variations. When being propagated 
through liquid, ultrasound may produce bubbles 
and cause them to grow, vibrate or collapse. This 
phenomenon is called cavitation. One of the uses for 
the phenomenon is beauty care-related fat removal, 
the aim of which is to cause fat cells to collapse by 
inducing microbubbles in them. Equipment based 
on the use of cavitation normally operates at very 
low frequencies (kHz), and the effect can usually be 
achieved with low power levels.
2.4 Information provided by ultrasound 
equipment concerning exposure
The safe use of ultrasound equipment requires 
information about the properties of the devices. 
These properties include the preset values set by 
the user, as well as the information the device 
provides to the user during use. Requirements 
for these properties have been set especially in 
standards concerning medical equipment.
The IEC 60601 series of standards includes 
three standards that address the safety 
requirements of ultrasound equipment. These 
are IEC 60601-2-5 (physiotherapy equipment) 
(IEC 2009), IEC 60601-2-37 (ultrasonic medical 
diagnostic and monitoring equipment) (IEC 2007a) 
and IEC 60601-2-62 (high intensity therapeutic 
ultrasound (HITU) equipment) (IEC 2013a). All 
three standards contain the chapter “Accuracy of 
controls and instruments and protection against 
hazardous outputs”, describing which parameters 
should be indicated to the user.
Physiotherapy equipment with continuous 
power must indicate the output power and the 
effective intensity. Physiotherapy equipment with 
modulated amplitude must display the temporal-
maximum intensity and the temporal-maximum 
output power.
The parameters listed above are subject to the 
following accuracy requirements:
•	 The output power shall not differ more than 
±20% from the actual value.
•	 The effective intensity shall not differ more 
than  ±30% from the actual value.
•	 The effective radiating area shall not differ 
more than ±20% from the actual value.
•	 The maximum effective intensity of any 
treatment head shall not exceed 3 W/cm². The 
limitation applies also in the case of a device 
failure as specified in the standard.
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Figure 1. Measurement system based on the use of a hydrophone. 
Figure from the report by SSM (Lindberg 2013).
Physiotherapy equipment must include a timer 
with a maximum timing not exceeding 30 minutes. 
The accuracy of the timer shall be better than 
±10% of setting.
The standard on ultrasonic medical diagnostic 
equipment states that if a device is not capable 
of exceeding the thermal index (TI) 1.0 on soft 
tissue or bone, it is not necessary for the device 
to indicate the thermal index to the user. This 
also applies to diagnostic equipment used on the 
skull area. If a ultrasound diagnostic device is not 
capable of exceeding the mechanical index (MI) 
1.0 through any method of use, it is not necessary 
to indicate the mechanical index. In case a device 
is capable of exceeding any of the index values 
mentioned above, the index must be indicated 
starting at value 0.4. The increment for the display 
of any index shall be no more than 0.2.
According to standard IEC 60601-2-62 (IEC 
2013a), high intensity therapeutic ultrasound 
equipment must always display the expected 
temperature rise at the ultrasound focus point 
during the treatment, the entry power, the effective 
intensity of the entry power, an indication in case 
cavitation occurs at the target location, the level 
of the reflected power, and the thermal equivalent 
time.
The technical report IEC/TR 62799 by IEC 
(IEC 2013b) presents alternative quantities that 
would offer better tools for describing the thermal 
effect of medical diagnostic equipment than the 
currently used TI. The technical report is fairly 
recent, and it can be assumed that the employment 
of new quantities is still at an experimental stage. 
For instance, the TETI (thermally equivalent time 
index) might offer a good indicator for thermal 
effects, as it takes time into account as well as the 
temperature, thus providing an improved way of 
indicating exposure.
2.5 Measuring ultrasound
Ultrasound that impacts the body can be 
measured in a water tank using a hydrophone. 
The measurement system is presented in figure 
1. Calibrated devices for low frequencies are not 
easily available. Additional information on carrying 
out the measurements is available in parts 1–3 of 
the standard IEC 62127 for medical applications 
(IEC 2007b+c+d).
The costs of the measurement systems have 
been estimated in a report commissioned by 
Strålsäkerhetsmyndigheten (SSM), the Swedish 
radiation protection authority (Lindberg 2013). 
According to the estimate, the price of a commercial 
hydrophone falls between EUR 7 000 and EUR 
24 000, depending on the manufacturer. According 
to the authors of the report, HIFU devices should 
be measured with a fiber optic sensor.
The standard IEC 61828 (IEC 2001) describes 
methods that can be used to specify the properties 
of the ultrasound field of a focused ultrasound 
device.
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3 Use of ultrasound in beauty care
Uses of ultrasound in beauty care include skin 
cleansing, facilitating conditioner absorption, 
skin rejuvenation and fat removal. In beauty 
care-related applications, the treatment head 
transmitting ultrasound is in direct contact with 
the body, allowing the ultrasound to penetrate into 
the body. The aim of the treatments is to induce a 
mechanical or thermal effect on the body through 
the use of ultrasound, leading to the desired results. 
For instance, in skin rejuvenation treatments, the 
objective is to warm the hypodermic layers and 
thus impact the skin’s collagen production. The 
aim of fat removal is to use ultrasound to break 
up the subcutaneous fat layer (cavitation), which 
should allow metabolism to process the fat out of 
the body  in time.
In recent years, the use of these devices has 
increased, and will likely continue to increase. The 
equipment is constantly developing, and new types 
of applications are introduced to the market every 
year at an increasing pace.
3.1 Frequency of use and 
number of devices
Radiation and Nuclear Safety Authority (STUK) 
oversees the use of non-ionizing radiation in 
beauty care services. Operators are not subject to 
any reporting or permit requirements. However, 
surveillance and interest group cooperation 
provide relatively comprehensive information on 
the frequency of use.
The Swedish radiation protection authority 
SSM conducted a survey on the beauty care-related 
ultrasound devices available in the Swedish market 
(Lindberg 2013). Ten devices were discovered, nine 
of which operated at frequencies between 25 and 
40 kHz and one at a frequency of 200 kHz. Other 
technical specifications (e.g., intensity, focal depth, 
constant/pulsing signal) were hard to find. In 
addition to ultrasound, all but one of the devices 
also utilized RF radiation, laser or both.
3.2 Ultrasound cavitation-
based procedures in Finland
In spring 2016, STUK conducted a survey on the 
services provided by cosmetologists in Finland. 
The survey covered beauty care service providers 
and medical clinics offering ultrasound cavitation. 
The survey was conducted via an internet search. 
The survey found a total of 81 beauty care service 
providers with websites containing the words 
cavitation and ultrasound. More than half (50) of 
the service providers only mentioned ultrasound 
and cavitation without specifying which devices 
or techniques they employed. The rest mentioned 
the device or its manufacturer, or the name was 
available in a device photo depicting the service. 
Five service providers also mentioned the 
frequency at which the device operates.
Terminology in the field varies, which is why, 
in some cases, it was not clear whether the service 
offered was actual ultrasound cavitation or just fat 
removal performed with the use of RF technology, 
as the word “cavitation” is sometimes erroneously 
used as a synonym for fat removal.
Mentions of the contraindications of the 
treatments varied. A total of 31 operators 
mentioned pregnancy as an obstacle to the 
treatment on their websites, or stated that it 
must be otherwise taken into account, such as by 
asking for a doctor’s approval for the treatment. 
The websites of 48 operators contained no mention 
of the contraindications whatsoever. Two websites 
could not be accessed due to a data security alert. 
In addition to the websites, the contraindications 
of the treatments may be covered at the place of 
treatment. This was not clarified. The treatment 
counter-indications mentioned on the websites 
of beauty care service providers are listed in 
Appendix 3.
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The survey also covered medical clinics 
and other healthcare units offering ultrasound 
cavitation treatments. All of them mentioned the 
device used to perform the treatment. As far as the 
topic was addressed on the websites, it seems that 
beauty care service providers and healthcare units 
use different equipment. The treatment counter-
indications mentioned on the websites of medical 
clinics are listed in Appendix 4.
In September 2016, STUK ran an internet 
search to collect information on the prices of 
ultrasound cavitation treatment. The search was 
targeted at the same group of operators found 
when searching for enterprises offering ultrasound 
cavitation. The treatment fees varied between 
EUR 40 and EUR 400 for the treatment of a 
single area. Increasing the number of treated areas 
in one treatment session normally reduced the 
average price, as did a series of several treatment 
sessions. The highest price for a single session was 
EUR 2 900, comprising treatment on 10 different 
areas. Some of the service providers stated that 
to ensure safety, no more than two areas can be 
treated during a single treatment session. Some 
of the service providers determined the price of 
the service on the basis of the time used on the 
treatment.
3.3 Accident cases in Finland
Finding information on the harmful health effects 
encountered in beauty care is difficult. There are 
no registers of equipment or treatment places, 
and in practice, operators do not report accidents 
or close-call situations to authorities. Thus, it is 
difficult to form a reliable image of accident cases 
and their number. Some cases of skin burns related 
to ultrasound use in Sweden and Norway have 
come to STUK’s knowledge thanks to cooperation 
between authorities. No cases have been reported 
in Finland.
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4 Possible health effects
Airborne ultrasound is nearly entirely reflected 
on the skin surface. Ultrasound can be coupled 
into the body keeping the source of exposure in 
direct contact with the skin, allowing the effects of 
ultrasound to reach the entire body. The effects of 
ultrasound on humans vary depending on whether 
the exposure is airborne or occurs via skin contact 
(Leighton 2007, HPA 2010). 
The health effects of ultrasound depend on 
the frequency and power level used. The effects 
are normally linked to threshold values, which 
means that they only occur when exposure exceeds 
a certain level. Sections 4.1–4.3 present possible 
effects caused by airborne exposure and exposure 
via skin contact, with a separate section on 
the exposure of pregnant women. The Ahmadi 
publication (2012) contains a list of the biological 
effects of both airborne and skin contact exposure.
4.1 Airborne exposure
Airborne ultrasound primarily affects the external 
organs, such as ears and eyes. Reported harmful 
effects include hearing loss, pain sensations, vertigo 
and tinnitus (WHO 1982, IRPA 1984, Lawton 2001, 
HPA 2010).
4.2 Exposure through skin contact
Various types of health effects are possible when 
ultrasound is conducted into the human body via 
a  transducer in direct skin contact. The effects 
largely depend on the method used, the power 
level and frequency, as well as the properties 
and temperature of the tissue. The effects have 
been extensively discussed in many compilation 
articles and reports (NCRP 2002, Leighton 2007, 
O’Brien 2007, Humphrey 2007, HPA 2010, SSK 
2012). Different types of health effects collected 
from these publications are presented below, 
taking into account comments by medical experts. 
All effects are not listed; instead, the point is to 
offer examples of the different types of possible 
effects. The examples do not address the likelihood 
or seriousness of the effects.
Harmful health effects are only caused if 
certain levels are exceeded. Possible cellular effects 
of ultrasound include tissue inflammation, blisters 
forming and damage to blood vessels and the 
nervous system. In addition, excess temperature 
rise caused by ultrasound may cause pain and 
result in necrosis in the tissue. Necrosis may also 
occur in tissue that has not been deliberately 
exposed. For example, due to bone’s high ultrasound 
absorption rate, bone necrosis may be caused by 
treatments that are targeted at a certain area of 
the body (e.g., buttocks and thighs) at frequent 
intervals.
Ultrasound can impact the movement of 
substances inside the body. This can be taken 
advantage of, as is the case in ultrasound-assisted 
drug distribution, conducted at frequencies 
of 20–100 kHz (low-frequency sonophoresis) to 
substances with a high molecular weight, and at 
frequencies higher than 700 kHz to substances 
with a low molecular weight (Polat 2011).
Ultrasound can also be used to heat up tissue. 
The temperature rise has uses in, for instance, 
traditional physiotherapy, which is covered in the 
healthcare standards sections of this report. If 
the treatment is not performed appropriately, the 
temperature rise may be too excessive. This may 
cause pain and lead to tissue damage. Rapidly 
rising temperature may even result in necrosis 
in the tissue. Rapidly heating up the skin may 
cause changes to the tissue, such as trabecular 
tightening (Wall 1999). One of the harmful health 
effects of temperature rise is tissue inflammation. 
This may also occur if, for instance, fat cells have 
been mechanically damaged.
The vibration may cause mechanical damage to 
the cell membrane, cell or cellular structure. This is 
made more likely by high ultrasound pressure and 
power levels, such as when using HIFU devices 
12
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for extracorporeal shockwave lithotripsy (ESWL) 
in health care. This effect is used deliberately in 
medical treatment, but it can also be utilized in 
beauty care. Related harmful effects may include 
cellular damage, structural damage and internal 
bleeding. They are most likely when the area to 
which ultrasound is applied contains tissue and/
or structures that do not require treatment. For 
instance, this may occur when the area to be 
treated is large, or ultrasound penetrates too deep 
or has not been sufficiently focused.
Momentary cavitation may cause cell 
membranes to open up and/or be damaged and cells 
and tissue structure to be destroyed. If this occurs, 
the tissues of the gas exchange system, such as the 
lungs and gas-containing liquids, are especially at 
risk. Small gas bubbles that already exist within 
the tissue, for instance, at the borders of lungs, may 
cause cavitation even at the ultrasound levels used 
for diagnostic purposes. This may cause damage to 
small vessels, which may result in microbleeding.
4.3 Exposure of pregnant women
Ultrasonography is widely used as an imaging 
technique during pregnancy, offering medical 
professionals detailed information about the 
fetus. Little research data is available on how the 
scanning affects the fetus, and the possibility of 
long-term effects cannot be excluded with certainty. 
However, the power levels used for imaging have 
not been found to have harmful health effects (HPA 
2010). Medical ultrasound examinations (including 
scans of the fetus) are conducted in large numbers 
(a total of 640 000 examinations in Finland in 2015) 
(Suutari 2016). Neither STUK nor the physicians 
consulted for this report have knowledge of cases 
involving harmful health effects.
In cases of cosmetic treatments involving power 
levels high enough to cause health effects to the 
tissue, it is possible that also the fetus is affected. 
Thus, for instance, undergoing a cavitation 
treatment for fat removal during pregnancy may 
also result in harmful health effects to the fetus.
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5 International recommendations
This chapter covers recommendations made by 
the most important international and national 
organizations concerning the airborne and skin 
contact-based use of ultrasound. A separate section 
has been dedicated to the devices used for medical 
purposes, as they are most widely used. Ultrasound 
has been utilized in health care for decades. The 
health effects of ultrasound are also best known in 
the field of health care, as many medical devices 
make use of the impacts that ultrasound has on 
tissues (e.g. gall stone lithotripsy).
ICNIRP (International Commission on 
Non-Ionizing Radiation Protection)
ICNIRP, the International Commission on 
Non-Ionizing Radiation Protection, makes 
recommendations for limitations on non-ionizing 
radiation. ICNIRP has published guidelines on 
limits of human exposure to airborne ultrasound 
(IRPA 1984). According to the guidelines, public 
exposure should be limited by keeping the sound 
pressure level under 70 dB at a frequency of 
20 kHz, and under 100 dB at frequencies between 
25 and 100 kHz. ICNIRP has started preparing 
new ultrasound guidelines. According to the 
leader of the group (Zenon Sienkiewicz), the target 
schedule for the guidelines’ first version, which 
will be sent out for external comments, is fall 2017. 
The guidelines will likely also address exposure 
via direct skin contact. ICNIRP has published a 
statement on diagnostic devices using non-ionizing 
radiation (ICNIRP 2017), which also discusses 
medical ultrasound scans.
WHO (World Health Organization)
The World Health Organization studied the 
health effects of ultrasound in the Environmental 
Health Criteria 22 report published in 1982 (WHO 
1982). WHO is currently working on an update 
to the ultrasound statement in collaboration with 
ICNIRP.
WFUMB (World Federation for 
Ultrasound in Medicine and Biology)
WFUMP is an international organization 
dedicated to the development of ultrasound use. 
The organization’s activities include supporting 
international cooperation and distributing 
scientific knowledge concerning ultrasound. The 
organization has nearly 50 000 expert members, 
including physicists, researchers, engineers and 
sonographers. Among the members of the WFUMB 
is the European Federation of Societies for 
Ultrasound in Medicine and Biology (EFSUMB). 
The members of EFSUMB, in turn, include national 
organizations from many European countries, such 
as the British Medical Ultrasound Society (BMUS).
WFUMB’s publications include the following 
statements on ultrasound safety (http://www.
wfumb.org/safety-statements/ ):
•	 The use of Doppler ultrasound should be 
restricted during weeks 11–14 or earlier in 
pregnancy by ensuring that the TI  ≤  1.0 and 
exposure time is kept as short as possible. The 
exposure time should normally be no longer 
than 5–10 minutes and should never exceed 60 
minutes.
•	 The organization disapproves of the use of 
ultrasound for the sole purpose of providing 
keepsake or souvenir images of the fetus, 
unless the images are taken during a clinical 
examination. The use of ultrasound for non-
medical purposes is not recommended 
unless carried out for education, training or 
demonstration purposes. When used for non-
medical purposes, the TI should be less than 0.7 
and the MI less than 0.3.
AGNIR (Advisory Group on 
Non-Ionising Radiation)
AGNIR is an independent advisory group on 
non-ionizing radiation. It reports to the English 
health authority Public Health England (PHE). 
14
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Commissioned by the Health Protection Agency 
(HPA), the predecessor of the PHE, AGNIR 
conducted a comprehensive study on the use and 
possible health effects of ultrasound (HPA 2010). 
The report also contains a comprehensive list 
of recommendations and limitations currently 
applied. Figure 2 contains a summary of the 
different sound pressure levels utilized in different 
applications.
The report by HPA also discusses the issue of 
fetal imaging. The report states that there is no 
reason to limit the clinical imaging of the fetus 
and the souvenir images created for the parents 
as a by-product. Carrying out the scans for the 
sole purpose of creating a souvenir image for the 
parents to keep is a different matter. The HPA also 
emphasizes that imaging requires expertise and 
training. According to the HPA, the popularity of 
this type of imaging is increasing, but it can be hard 
to justify as it offers no clinical benefits. According 
to HPA’s recommendation, ultrasound scans should 
only be carried out by medical professionals who 
have been trained in ultrasound safety. Moreover, 
if something unusual is discovered from the scan, 
they are able to offer advice and the necessary 
instructions. As the scans have not been clearly 
proven to pose a health risk, future parents must 
make the decision of whether or not they want to 
have the images.
AIUM (American Institute of 
Ultrasound in Medicine)
AIUM is a multi-disciplinary medical association 
with a membership comprising more than 9 000 
physicians, sonographers, researchers, students 
and other health care providers. AIUM is 
committed to promoting the safe and efficient use 
of ultrasound in medicine by training professionals 
and members of the public, conducting research, 
preparing recommendations and granting 
accreditations.
According to AIUM (Fowlkes 2008), a 
temperature rise of 2°C from the normal 37°C 
temperature induced with ultrasound does not 
cause any adverse biological effects during an 
exposure period of 50 hours (Fowlkes 2008). If 
the temperature rises 2–6°C above normal, the 
harmful biological effects become time-dependent. 
This dependency is presented in the formula:
If the temperature rises more than 6°C, the time 
dependency is strengthened:
A formula has been specified for exposure of less 
than five seconds:
In formulas 1, 2 and 3, time t is indicated as 
seconds. Figure 3 contains a graphic presentation 
of the relationship between temperature and time, 
which has been derived from these formulas.
The formulas above are not applicable in situations 
in which radiation is targeted at a fetus. The fetus 
may develop serious developmental disorders if 
ultrasound increases its temperature by 4°C for a 
time longer than five minutes.
NCRP (National Council on 
Radiation and measurement)
In the United States, ultrasound has been used 
in health care and beauty care for a long time. 
NCRP has published three reports concerning 
ultrasound exposure (primarily related to medical 
imaging) and its health effects. The most recent 
of the reports (NCRP 2002) also covers other 
effect mechanisms in addition to those related to 
temperature increase.
Health Canada
Health Canada is the Canadian federal department 
responsible for maintaining and improving public 
health in Canada.
Health Canada (2001) has published 
recommendations for the use of ultrasound in 
diagnostics and medical, industrial and commercial 
applications. According to the recommendations, 
in medical use, the mechanical index produced 
by the device should be equal to or less than 1.9, 
and the derated spatial-peak temporal average 
intensity (Ispta.3) equal to or less than 720 mW/cm². 
For devices targeting ultrasound at the eye, the 
(1)
(2)
(3)
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equivalent recommended maximum values are 
0.23 and 50 mW/cm², respectively. For monitoring 
the fetal heartrate, the maximum recommended 
value is 20  mW/cm². According to the report, 
temperature increase poses a risk to the fetus when 
the following exposure durations are exceeded:
•	 39°C: 60 minutes
•	 40°C: 15 minutes
•	 41°C: 4 minutes
•	 42°C: 1 minutes
•	 43°C: 0.25 minutes.
Health Canada (1991) recommends that contact 
with a powerful source of ultrasound should always 
be avoided in industrial and commercial activities. 
The publication contains recommendations on 
reaching this objective. Table 1 contains the Health 
Canada (1991) recommendations as limiting values 
for airborne ultrasound.
Standards concerning ultrasound 
devices (IEC/CENELEC)
Some of the standards published by the 
International Electrotechnical Commission 
(IEC) and the equivalent European organization 
European Committee for Electrotechnical 
Standardization (CENELEC) cover safety factors 
related to the use of ultrasound. Part  1 of the 
standard IEC  60601 on medical equipment 
specifies general safety instructions to all medical 
electrical equipment (IEC 2005). The related 
standards on medical ultrasonic equipment do not 
set exposure limits to ultrasound (IEC 2009 and 
IEC 2007a).
In the IEC/EN standards for medical equipment, 
the safety requirements are based on the following 
different quantities depending on the purpose of 
use of the device:
•	 For physiotherapy equipment (60601-2-5), the 
effective output intensity per area, 3 W/cm2.
•	 The safety effects of medical diagnostic 
equipment (60601-2-37) are assessed through 
the mechanical index (MI) and the thermal 
index (TI). The indexes are calculated using 
formulas 4 and 5, which are presented in 
standard IEC 62359 (IEC 2010). According 
to current knowledge, cavitation will not 
occur if the MI is below 0.7. A specification 
of the mechanical index in frequencies under 
500 kHz (Figure 6) is presented in the Ahmadi 
publication (2012).
•	 There are separate standards for surgical 
operations, dental calculus removal and 
lithotripsy.
•	 For some devices, such as extracorporeal shock 
wave lithotripsy and HIFU equipment, no 
standards are available (Duck 2007).
The standard IEC 62359 (IEC 2010) describes the 
tests used to specify the indexes.
MI
peakrarefactional pressure MPa
pulsemedium frequency
=
( )
( )MHz
TI
transmitter output power W
the power requiredtoachie
=
( )
ve increaseinthetemperatureintissue W( )1°C
MI
peakrarefactional pressure MPa ambient pressure M
LF =
( ) − ( Pa
pulsemedium frequency MHz
)
( )
(4)
(5)
(6)
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Figure 2. Sound pressure levels and applications as functions of frequency. Figure from the HPA report (2010).
Figure 3. A graphic presentation of the relationship between temperature and time, indicating the conservative 
limit for exposure times, when the target of exposure is not a fetus. The figure is from the AIUM report (Fowlkes 
2008), taken from the article by O’Brien et al. (2008).
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Table 1. Health Canada’s (1991) recommendations as the limiting values for airborne 
 ultrasound. The limiting values are indicated in decibels, using sound pressure 
20 µPa as the reference level. The frequencies are indicated for 1/3-octave bands.
1/3-octave band [kHz] Sound pressure level limiting value [dB]
16 75
20 75
25 110
31.5 110
40 110
50 110
18
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6 Regulation and control
The division between medical and cosmetic 
treatments is not straightforward, as some 
procedures are performed for both purposes. Thus, 
in many countries, both types of treatment are 
governed by the same norms.
6.1 Legislation in Finland
The medical use of ultrasound is subject to the 
Radiation Act (592/1991). The Radiation Act 
specifies no limits to ultrasound exposure. The 
safety of medical equipment is also regulated by 
the Act on Healthcare Equipment and Supplies 
(629/2010). The general provisions in the Consumer 
Protection Act (920/2011) are applied to the safety 
of consumer products and services. Currently, the 
Radiation Act contains no regulations related 
to the topic at hand. The draft of the Radiation 
Act currently being prepared covers non-medical 
exposure to ultrasound.
No uniform legislation or practices exist at EU 
level concerning the non-medical use of ultrasound. 
The directive concerning medical devices (EU 
1993) will be replaced with an EU regulation (EU 
2016) in the near future. The current version of 
the regulation also covers cosmetic devices. The 
application restrictions do not directly refer to 
ultrasound, but, depending on the interpretation, 
equipment such as ultrasound devices used for 
fat removal may be interpreted as high-energy 
equipment, thus falling within the regulation’s 
scope of application. The EU regulation 1223/2009/
EC on cosmetic products (EU 2009) discusses 
substances and mixtures used in contact with 
the external parts of the human body. Thus, the 
regulation is not applied to cosmetic devices 
impacting the internal parts of the body, or the 
treatments carried out using the devices.
According to statements STM/970/2014 
and STM/985/2016 by the Finnish Ministry of 
Social Affairs and Health, demanding cosmetic 
treatments should only be carried out at health care 
units, regardless of whether they are conducted for 
aesthetic or medical reasons. Treatments such as 
ultrasound-based fat removal can be regarded as 
demanding cosmetic treatments.
6.2 Legislation in other countries
In Sweden, ultrasound equipment used for beauty 
care are not classified as medical devices, and 
they are not controlled by Läkemedelsverket, the 
authority responsible for monitoring medicinal 
substances. If necessary, Läkemedelsverket can 
classify a device as medical, if it deems that the 
use of the device involves great risks. The Swedish 
radiation protection authority SSM is also working 
to clarify the safety issues related to ultrasound, 
including the necessity of surveillance. In Sweden, 
it has been suggested that all treatments of this 
type should be banned for people under 18 years 
of age.
In Germany, the Strahlenschutzkommission 
published a report and proposal concerning 
the medical and non-medical use of ultrasound 
in 2012 at the commission of Bundesamt für 
Strahlenschutzin (BfS) (SSK 2012). The proposal 
included suggestions for bans or warnings 
concerning the use of ultrasound in imaging and 
treatment for non-medical purposes. Among the 
suggestions was the proposal to ban the use of 
HIFU equipment in beauty care when treatment is 
carried out for non-medical purposes. The proposal 
also mentioned introducing certifications for 
the users of the devices in order to ensure that 
those carrying out the procedures have sufficient 
knowledge and skills concerning ultrasound 
treatment. Based on information acquired from 
Bundesamt für Strahlenschutz in September 2016, 
the legislation is currently being prepared.
In France, a legal ban was introduced in 2011 
prohibiting cosmetic fat removal procedures 
utilizing focused ultrasound, laser equipment, 
infrared radiation or radio frequency radiation 
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(Légifrance 2011). The law was amended in 2012, 
lifting the ban on the use of focused ultrasound, 
infrared radiation or radio frequency radiation. 
In France, a decree is currently being prepared 
to prohibit non-medical imaging of fetuses (EU 
notification 2016).
In Italy, a draft decree has been introduced 
addressing cosmetic treatments on the basis of 
medical equipment standards. The draft is very 
detailed and contains guidelines and requirements 
specifically for each type of device (EU notification 
2015).
In the United States of America, ultrasound has 
been used in health care and beauty care for a long 
time. The US Food and Drug Administration (FDA) 
has classified aesthetic ultrasound equipment as 
sufficiently high-risk to be regarded as medical 
equipment and processed in accordance with 
medical standards, falling under risk class II (FD 
2011a, FDA 2011b).
In Canada, the requirements for medical 
radiation appliances are specified in two acts: 
the Food and Drugs Act (Canada 2016a) and the 
Radiation Emitting Devices Act (Canada 2016b). 
The decrees Medical Devices Regulations (Canada 
2016c) and Radiation Emitting Devices Regulations 
(Canada 2016d) are also related. References 2016a, 
2016b and 2016c cover medical devices in general 
and do not set any detailed requirements. Part 
XIII of reference 2016d concerns ultrasound 
therapy equipment. For these equipments, the set 
maximum value of ultrasound intensity is 3 W/cm² 
(temporal and spatial average). Besides this limit, 
the focus of the requirements is on ensuring that 
the parameters indicated on the devices are correct 
and that the warning markings on the devices are 
appropriate.
20
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7 Infrasound
Infrasound is sound with frequencies below the 
lower limit of human hearing (<20 Hz). In general, 
the safety of infrasound has been studied very 
little both on the national and the international 
level. ICNIRP has no recommendations concerning 
infrasound, and according to current knowledge, 
none are being prepared. Moreover, no uniform 
standards or limitations have been established for 
infrasound. Infrasound can be used for treatment 
purposes, for example in physioacoustic therapy. It 
can also be used as a sonic weapon in military and 
police use. Recently, discussion about infrasound 
has arisen due to wind farms, as they cause noise 
in the infrasound frequency range.
At EU level, infrasound has been addressed 
as a part of the directive on noise (EU 2003), but 
no safety limits are set. According to the article 
by Duck (Duck 2007), the only recommendations 
available in 2007 were recommendations made by 
the American Conference of Government Industrial 
Hygienists (ACGIH 2001). According to the ACGIH 
guidelines, for frequencies between 1–80 Hz, the 
sound pressure level should not exceed 145 dB, and 
the overall SPL should not exceed 150 dB when the 
commonly used frequency component weighting for 
audible sound is not applied.
The publication by the Health Protecting Agency 
(HPA 2010) mentions that Japanese guidelines 
recommend a limit of 92 dBG for infrasound 
generated by wind turbines. The G-weighted 95–
100 dBG is close to the threshold of perception, 
whereas 85–90 dBG is normally not audible to 
humans.
Infrasound does not fall within the scope of 
application of the Radiation Act. No proposal has 
been made to include infrasound in the scope 
of application of the new Radiation Act, as no 
convincing evidence exists of health effects of 
infrasound or the related threshold levels. This 
information would be necessary to establish 
limitations to exposure. Similarly to ultrasound, 
both ICNIRP and WHO classify infrasound under 
non-ionizing radiation.
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8 Conclusion and reflection
Safety limits
Based on this survey, the non-medical use of 
ultrasound in fields such as beauty care involves 
risks, and the number of applications available 
is rapidly increasing. Establishing limiting values 
for exposure is necessary, especially to ensure 
the safety of consumer services. Internationally 
approved safety limitations for the non-medical 
applications of ultrasound are not currently 
available; therefore, the limiting values for 
exposure should be established on the national 
level. The threshold levels of harmful health effects 
have been assessed in the reports by SSK and HPA 
(SSK 2012 and HPA 2010), and medical equipment 
standards also contain useful information. These 
sources are sufficient for establishing limitations 
based on scientific evidence.
Appendix 1 contains a proposal for the 
limitation of exposure to ultrasound. The proposal 
to limit ultrasound exposure via direct skin contact 
is based on limiting temperature increase and the 
mechanical effects. In the decree of the Ministry 
of Social Affairs and Health (294/2002), limiting 
electric or magnetic fields with a frequency above 
100 kHz (RF radiation) is based on temperature 
rise. Even though the energy transmitted to the 
body is produced in different ways for RF radiation 
and ultrasound, the limitations of both are based 
on limiting temperature rise. With regards to 
ultrasound, the mechanical effects caused are also 
taken into account.
The aim of the levels presented in Tables 2 and 
3 of Appendix 1 is to make it easier to determine 
the exposure to ultrasound via skin contact in non-
medical use. The objective of the levels in Table 
2 is to ensure that the use of ultrasound causes 
no harmful health effects. Safety limits proposed 
by various international organizations (WFUMB, 
AIUM, SSK, HPA, NCRP) differ slightly from one 
another. The values in Table 2 are consistent with 
the proposal by SSK. The limit of the mechanical 
index would be 0.4. The equivalent limit proposed 
by WFUMB is 0.3, while NCRP has proposed 0.5. 
Similarly, the limit of the thermal index would be 
0.7, whereas WFUMB has proposed the value 0.5 
and NCRP the value 1. When ultrasound exposure 
exceeds the levels in Table 2, it is necessary to 
take measures to ensure that no harmful tissue 
damage or changes to vital functions occur. Safety 
can be improved by factors such as the equipment 
technique used, the competence of the user, 
instructions and monitoring the health of the 
customer.
As mitigation, a STUK regulation could be 
applied to cosmetic use if safety of use can be 
otherwise ensured. The mitigation could be 
justified by the fact that equipment standards are 
constantly developing, users are well trained, and 
there are other means to ensure that no harmful 
heath effects occur and vital functions are not 
risked.
The typical energy density levels of ultrasonic 
applications used in health and beauty care are 
presented below, along with the action levels 
proposed in Appendix 1. In addition to the energy 
density of the treatment period, the local duration 
must also be taken into account, as it significantly 
affects the energy received by the tissue. 
Treatments with the highest energy density last 
at most a few seconds. Very high power may result 
in rapid heating of the tissue and tissue necrosis 
if local exposure lasts too long. HIFU devices are 
used in medical ultrasound treatment equipment 
for purposes such as destroying fat cells.
Typical energy density levels of ultrasonic 
applications include:
•	 1000–10 000 W/cm²: the intensity of HIFU 
equipment
•	 10–30 W/cm²: lithotripsy
•	 2–25 W/cm²: fat removal through cavitation
•	 3 W/cm²: the maximum allowed intensity of 
physiotherapy equipment
0.1–1 W/cm²: skin cleansing, psoriasis treatment
•	 0.1 W/cm²: proposed intensity level for exposure 
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targeted at the body
•	 0.05–2 W/cm²: physiotherapy treatment
•	 0.05 W/cm²: proposed intensity level for 
exposure targeted at the eyes
•	 0.001–0.03 W/cm²: home-use devices meant for 
monitoring fetal heartbeat.
Of all procedures commonly carried out, at least 
fat removal cavitation exceeds the ultrasound 
limitations presented in Appendix 1. Based on 
the proposal, providing this type of practice as a 
consumer service would be prohibited. However, 
the procedures could be carried out by a medical 
professional. Comments from physicians with 
expertise in ultrasound support this conclusion. 
As relevant factors, the physicians mentioned that 
fat removal cavitation is comparable to surgical 
procedures, and that for risk management, the 
user must have in-depth knowledge of anatomy 
and physiology, which only a trained physician 
would possess.
It is important to acknowledge multi-use 
devices (ultrasound and laser and/or RF in the 
same device) and the special characteristics of both 
their regulatory control and the exposure they 
cause. The current Radiation Act (592/1991) and 
the Ministry of Social Affairs and Health Decree on 
the Limitation of Public Exposure to Non-Ionizing 
Radiation (294/2002) do not clearly specify the 
joint effect of different radiation techniques with 
relation to the maximum values, as equipment 
producing more than one type of radiation has not 
been available before. When preparing the new 
legislation, the limiting values should be specified 
to incorporate the joint effect of different types of 
radiation in the limitations based on temperature 
rise.
Regulatory control
At the moment, the non-medical use of ultrasound, 
for instance in beauty care, is governed by the 
general provisions of the Consumer Protection Act. 
This means the primary regulatory authority is the 
Finnish Safety and Chemicals Agency (Tukes). If 
requirements concerning the safety of ultrasound 
are added to radiation-related legislation, STUK 
could take over the regulatory control, as the 
procedures of operators currently monitored, 
such as RF or laser treatments, already fall under 
STUK’s authority.
All medical devices are subject to the 
Medical Devices Act. The supervisory authority 
of these operators and health care units is the 
National Supervisory Authority for Welfare and 
Health (Valvira). Depending on the final scope 
of application of the pending EU regulation on 
medical devices (EU 2016), ultrasound equipment 
could be placed under the scope of application of 
medical legislation even when used for cosmetic 
purposes.
Products sold to consumers are currently 
subject to the general provisions of the Consumer 
Protection Act. This makes Tukes the primary 
supervisory authority. Adding ultrasound-related 
requirements to radiation legislation would allow 
STUK to act on any dangerous products detected 
in the market.
The aim should be to avoid unnecessarily 
restricting cosmetic procedures if they can be 
carried out safely. However, it is also important to 
leave more demanding procedures to be carried out 
by medical professionals. When incorrectly used, 
equipment such as ultrasound devices used for 
body modification may cause serious damage in 
the body.
Pregnant women
There is no evidence to support the notion that 
ultrasound imaging poses a risk to the fetus. 
Based on expert comments, it might be sensible 
to prohibit people without medical training from 
carrying out fetal ultrasound scans as consumer 
services. Similarly, the use of 3D devices was only 
viewed as justified on clear medical grounds. Many 
organizations (including AIUM, BMUS, FDA, 
Health Canada, EFSUMB) have reached the same 
conclusion. According to HPA’s recommendation, 
ultrasound scans should only be carried out by 
medical professionals who have been trained in 
ultrasound safety. In France, a decree is being 
prepared to prohibit the non-medical imaging of a 
fetus. The report did not mention bans on the non-
medical imaging of a fetus in any other European 
countries.
Cosmetic procedures involving high power 
levels should not be performed on pregnant women, 
especially without a trained medical professional 
overseeing the procedure. This makes it possible 
to avoid the high risk of harmful health effects 
involved in these procedures.
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APPENDIX 1 ProPosal for the limitation of exPosure to ultrasound
Limiting exposure to airborne ultrasound
The harmful health effects of airborne ultrasound can be prevented by limiting sound pressure levels. 
Limiting values for ultrasound pressure level (SPL) at different frequencies are presented in Table 1.
Table 1. Limiting values for ultrasound pressure level (SPL) at different frequencies. The 
limiting values are indicated in decibels, using sound pressure 20 µPa as the reference 
level. The frequencies are indicated in 1/3-octave bands.
1/3-octave band [kHz] Ultrasound pressure level (SPL) [dB]
20 70
25 100
31.5 100
40 100
50 100
63 100
80 100
100 100
Restricting exposure to ultrasound in direct skin contact
Ultrasound may not cause harmful tissue damage or changes to vital functions due to tissue heating. 
Temperature rise of not more than one degree can be considered safe regardless of the time of exposure.
In addition, the mechanical impacts of ultrasound (pressure, power, etc.) may not cause harmful tissue 
damage or changes to vital functions.
When exposing pregnant women to ultrasound, the safety of the fetus must be ensured in particular.
The restrictions presented are not applicable to the medical use of ultrasound.
Ultrasound exposure is defined either through intensity or the mechanical index (MI) and thermal 
index (TI). Harmful health effects can be safely avoided if the levels presented in Table 2 are not 
exceeded. When ultrasound exposure exceeds these levels, it is necessary to take measures to ensure that 
no harmful tissue damage or changes to vital functions occur. Safety can be improved by factors such as 
the equipment technique used, the competence of the user, instructions and monitoring the health of the 
customer. Table 3 presents the levels below which harmful health effects are not likely to occur.
Table 2. Levels for ultrasound intensity and the mechanical index (MI) and 
thermal index (TI), under which no harmful health effects are caused.
Body part Ultrasound 
intensity 
[W/cm2]
Mechanical 
index 
(MI)
Thermal 
index 
(TI)
Eyes 0.05 0.2
0.7
Other parts 0.1 0.4
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APPENDIX 1  ProPosal for the limitation of exPosure to ultrasound
Table 3. The levels of the mechanical index (MI) and the 
thermal index (TI) below which harmful health effects are 
not likely to occur.
Mechanical index (MI) Thermal index (TI)
0.7 1
28
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APPENDIX 2 indicative list of contraindications to be taken 
 into account in beauty care
The list is based on a survey conducted with medical experts inquiring their opinion on the important 
contraindications of using ultrasound treatment in beauty care. Contraindications include:
•	 cardiac pacemaker
•	 serious cardiovascular diseases
•	 thrombosis
•	 vasculitis
•	 chronic circulation insufficiency 
•	 diabetes
•	 anticoagulant medication
•	 renal or hepatic insufficiency or hypothyroidism
•	 cancer or a tumor
•	 implants in the treatment area
•	 morbid obesity
•	 pregnancy or breast-feeding
•	 metal implants
•	 age under 18 
•	 acute infection
•	 open wounds in the treatment area
•	 suspicious lymph glands
•	 previous surgical operations to the abdomen
•	 scars in the treatment areas
•	 skin diseases, malignant skin transformation
•	 numbness
•	 serious psychological disorders and related medication (e.g., depression)
•	 osteoporosis.
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APPENDIX 3 contraindications of cavitation treatments in beauty care
Contraindications of cosmetic cavitation treatments mentioned on the websites of beauty care service 
providers: 
•	 coronary thrombosis
•	 cardiac pacemaker
•	 cardiac failure
•	 serious cardiovascular diseases
•	 aneurysm
•	 thrombosis
•	 vasculitis
•	 chronic circulation insufficiency
•	 blood clot
•	 immunological diseases
•	 hepatitis
•	 high cholesterol
•	 anticoagulant medication
•	 ovarian cyst
•	 hysterectomy or a surgical operation within the past 12 months
•	 kidney or liver dysfunction
•	 renal or hepatic insufficiency or hypothyroidism
•	 cholelithiasis
•	 untreated arterial hypertension
•	 cancer or a tumor
•	 hysteromyoma
•	 implants in the treatment area
•	 diabetes
•	 epilepsy
•	 asthma
•	 morbid obesity
•	 pregnancy or breast-feeding
•	 metal implants
•	 age under 18 
•	 illness or fever
•	 acute infection or inflammations
•	 duodenal or gastric ulcer
•	 open wounds in the treatment area
•	 suspicious lymph glands
•	 previous surgical operations to the abdomen
•	 early phase of period
•	 skin diseases, malignant skin transformation
•	 numb area of skin
•	 damage to middle or inner ear
•	 tinnitus or equivalent hearing problems
•	 serious psychological disorders and related medication (e.g., depression)
•	 anorexia or bulimia
•	 osteoporosis.
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APPENDIX 4 contraindications of medical cavitation treatments
Contraindications of cosmetic cavitation treatments mentioned on the websites of medical clinics:
•	 BMI above 30
•	 morbid obesity
•	 surgical operation carried out on the treatment area
•	 subcutaneous fat layer too thin
•	 severe underlying diseases
•	 hepatitis
•	 very high cholesterol
•	 past or recent coronary thrombosis
•	 cardiac pacemaker
•	 implants
•	 kidney dysfunction
•	 liver dysfunction
•	 untreated arterial hypertension
•	 cancer or a tumor
•	 being HIV positive
•	 bleeding tendency or, for instance, Marevan medication
•	 weakened physical health and metabolism
•	 infection
•	 certain skin diseases
•	 serious diseases of lipometabolism
•	 immunosuppressive medication
•	 implants in the treatment area
•	 diabetes
•	 epilepsy
•	 pregnancy or breast-feeding
•	 age under 18
•	 age over 65
•	 illness or fever
•	 early phase of period.
